A Leading Location
The German capital region provides outstanding potential for development and ideal conditions for the biotechnology and pharmaceuticals industry. Its major strengths are a unique research landscape and a close network of the players along the entire value-added chain. Its many technology parks and networks in various fields of modern biotechnology provide an excellent infrastructure and form the technological backbone of the biotechnology and pharmaceuticals industry in Berlin and Brandenburg.
Are you planning on developing your company’s presence in the German capital? A good choice! We will help you implement your decision to locate or expand your company in Berlin-Brandenburg.
Pfizer is constantly exploring opportunities for partnerships and invites you to submit a research collaboration proposal for the 1st Pfizer Biotech Partnering Days on October 4–5, 2016 in Berlin.
Berlin, 2 August 2016. In the first half of the year, Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE 0005659700), a specialist for isotope-based applications in medicine, science and industry headquartered in Berlin,...
SCIENION and Applied Microarrays announce a strategic partnership to deliver next generation medical devices
SCIENION AG, a solution provider for precise liquid dispensing applications, and Applied Microarrays, Inc. the recognized leader in manufacturing services for multiplexed testing, today announced a strategic partnership to enable...
Entrance Markgrafenstraße 38
The German Conference on Bioinformatics (GCB) is an annual, international conference devoted to all areas of bioinformatics. Recent meetings attracted a multinational audience with 250 – 300 participants each year. The meeting is...
Nils Ericsons Plan 4
The largest Nordic partnering conference for the global Life Science industry / HealthCapital Berlin-Brandenburg is acting as conference supporter / Early Bird rates apply!